We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.78%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$740M
AUM Growth
-$36.8M
Cap. Flow
-$52.8M
Cap. Flow %
-7.13%
Top 10 Hldgs %
47.01%
Holding
218
New
17
Increased
75
Reduced
83
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 13.69%
2 Industrials 8.67%
3 Consumer Discretionary 5.55%
4 Financials 5.26%
5 Healthcare 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
101
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$883K 0.12%
22,429
-24,699
-52% -$1.03M
JPM icon
102
JPMorgan Chase
JPM
$933B
$872K 0.12%
13,208
+214
+2% +$13.9K
BAC icon
103
Bank of America
BAC
$433B
$861K 0.12%
51,169
-692
-1% -$11.7K
KO icon
104
Coca-Cola
KO
$381B
$818K 0.11%
19,035
-63
-0.3% -$2.67K
CL icon
105
Colgate-Palmolive
CL
$73.3B
$815K 0.11%
12,235
+473
+4% +$31.5K
GILD icon
106
Gilead Sciences
GILD
$163B
$807K 0.11%
7,978
+770
+11% +$80.1K
MGK icon
107
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.1B
$807K 0.11%
48,600
-4,140
-8% -$69.5K
WBA
108
DELISTED
Walgreens Boots Alliance
WBA
$771K 0.1%
9,053
+216
+2% +$18.3K
KMB icon
109
Kimberly-Clark
KMB
$36.6B
$716K 0.1%
5,628
+246
+5% +$29.5K
AXP icon
110
American Express
AXP
$228B
$665K 0.09%
9,554
HD icon
111
Home Depot
HD
$332B
$655K 0.09%
4,953
+1,161
+31% +$148K
MDY icon
112
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$596K 0.08%
2,347
+1,537
+190% +$400K
BMY icon
113
Bristol-Myers Squibb
BMY
$132B
$567K 0.08%
8,248
+4
+0% +$264
SH icon
114
ProShares Short S&P500
SH
$913M
$564K 0.08%
3,377
+2,082
+161% +$349K
IDXX icon
115
Idexx Laboratories
IDXX
$44.1B
$554K 0.07%
7,600
RTX icon
116
RTX Corp
RTX
$289B
$553K 0.07%
9,142
-754
-8% -$45.6K
D icon
117
Dominion Energy
D
$61.3B
$550K 0.07%
8,138
-707
-8% -$48.8K
IGSB icon
118
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$542K 0.07%
10,372
-841,176
-99% -$44.2M
DUK icon
119
Duke Energy
DUK
$98.4B
$525K 0.07%
7,347
+92
+1% +$6.47K
ADP icon
120
Automatic Data Processing
ADP
$105B
$519K 0.07%
6,129
+84
+1% +$7.24K
PM icon
121
Philip Morris
PM
$299B
$519K 0.07%
5,903
+320
+6% +$27.8K
VEU icon
122
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
$507K 0.07%
11,681
-1,634
-12% -$73.1K
MFC icon
123
Manulife Financial
MFC
$74B
$498K 0.07%
33,258
+2,552
+8% +$41.2K
HON icon
124
Honeywell
HON
$76.7B
$495K 0.07%
5,315
+156
+3% +$14.3K
MRK icon
125
Merck
MRK
$321B
$481K 0.07%
9,557
+493
+5% +$24.9K

Similar funds

Grimes & Company's Q4 2015 Portfolio in Review

As of Q4 2015, Grimes & Company held 218 positions worth $740M, down 4.7% from $777M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Grimes & Company withdrew a net $52.8M in Q4 2015, closing 10 positions and reducing 83 holdings. Its most notable exit was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Grimes & Company opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $41.2M.

  • Grimes & Company's largest Q4 2015 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 389,108 shares worth $41.2M.
  • Grimes & Company added most to State Street SPDR S&P 500 ETF Trust in Q4 2015, an estimated $8.31M increase.
  • Grimes & Company's biggest Q4 2015 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $44.2M.
  • Grimes & Company fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2015, selling an estimated $44.1M.
  • Grimes & Company's ten largest holdings make up 47% of its $740M portfolio in Q4 2015.
  • Grimes & Company opened 17 new positions and closed 10 in Q4 2015.
  • Grimes & Company's portfolio value fell 4.7% quarter-over-quarter to $740M.

Based on Grimes & Company's 13F filing for Q4 2015, filed 3 Feb 2016.